Planned Clinical Trial on Green Cardamom for Type 2 Diabetes

Background on Diabetes and Cardiovascular Disease

Diabetes mellitus (DM) and cardiovascular disease pose significant global health challenges, contributing to high rates of morbidity and mortality. These conditions often coexist, with diabetes recognized as a risk factor for cardiovascular complications.

Potential of Complementary Approaches

Exploring complementary and alternative methods for managing chronic diseases like diabetes and cardiovascular issues may enhance health outcomes and improve long-term prognoses for affected individuals.

Properties of Green Cardamom

Green cardamom, a spice belonging to the ginger family, is noted for its antioxidant, anti-inflammatory, and anti-carcinogenic properties. While some research indicates it may lower lipid levels and improve glucose metabolism, findings are not universally consistent across studies.

Details of the Upcoming Study

A research team from Iran has announced a forthcoming randomized, placebo-controlled clinical trial aimed at evaluating the effects of cardamom on diabetes control and oxidative stress in individuals diagnosed with type 2 diabetes. The study will be published in the journal BMC Complementary and Alternative Medicine.

Study Design and Methodology

Eighty overweight or obese participants with type 2 diabetes will be randomly allocated to either a cardamom group or a placebo group. Both groups will maintain their existing diabetes management regimens. Participants in the intervention group will consume two capsules of cardamom at each meal, totaling three grams daily, for a duration of ten weeks.

Data Collection and Assessment

Researchers will collect various data points, including HbA1C, insulin levels, fasting blood glucose levels, lipid profiles, and oxidative stress markers such as sirtuin-1 and irisin. Assessments will take place at the beginning of the trial and again after ten weeks of supplementation or placebo. Changes in body mass index, dietary intake, and physical activity levels will also be evaluated.

Significance of the Study

This study is poised to be the first randomized controlled trial to investigate the potential of cardamom as a safe and effective treatment for diabetes management. Researchers suggest that alterations in oxidative biomarkers, such as sirtuin-1 and irisin, in participants receiving cardamom may elucidate the mechanisms through which cardamom could provide protective benefits for diabetes and lipid control.

Author Information

This article was written by Suzanne M. Robertson, Ph.D.

Related Topics

– Plant Protein Lowers Risk of Type 2 Diabetes
– Benefits of Raspberries for Prediabetes
– Is Turmeric Beneficial for Diabetes?
– The Connection Between Macronutrient Intake, Metabolic Syndrome, and Type 1 Diabetes
– Is Honey Safe for Diabetics?
– How Night Owl Habits Can Increase Risk of Weight Gain and Diabetes

Reference

Aghasi, Mohadeseh, et al. “The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial.” BMC Complementary and Alternative Medicine 18, no. 1 (2018): 18.